Stephen R. Karpen
Breakthrough(US)
Publications by Year
Research Areas
Diabetes Management and Research, Pancreatic function and diabetes, Diabetes and associated disorders, Asthma and respiratory diseases, Cystic Fibrosis Research Advances
Most-Cited Works
- → C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis(2023)47 cited
- → Effective Data Sharing as a Conduit for Advancing Medical Product Development(2021)32 cited
- → Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting report(2020)20 cited
- → TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial(2024)18 cited
- → Effects of exercise intensity compared to albuterol in individuals with cystic fibrosis(2014)15 cited
- → Moderate intensity exercise mediates comparable increases in exhaled chloride as albuterol in individuals with cystic fibrosis(2015)13 cited
- → Impaired cardiac and peripheral hemodynamic responses to inhaled β2-agonist in cystic fibrosis(2015)11 cited
- → Leveraging Real‐World Data for EMA Qualification of a Model‐Based Biomarker Tool to Optimize Type‐1 Diabetes Prevention Studies(2022)10 cited
- → Academic Entitlement: A Student’s Perspective(2014)10 cited
- → The Role of Patient-reported Outcomes and Medication Adherence Assessment in Patient-focused Drug Development for Solid Organ Transplantation(2021)9 cited